AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
AGORA PRS Seminar | February 10th
Events
International Day of Women and Girls in Science | February 11th
Events
You are invited: AGORA Apéro | February 12th
Events
PhD Thesis Defense | February 27th
Events
AGORA Single-cell omics meetings | March 4th
Events
AGORA PRS Special Guest Seminar, Prof. Leila Akkari | March 10th
Latest publications
Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.
Bejarano L, Hernández-Barranco A, Roh V, (…), Hegi ME, Fournier N, Joyce JA
Cell Reports – 2026 Feb 24
CCL3 is produced by aged neutrophils across cancers and promotes tumor growth
Bolli E, Wirapati P, Hicham M, (…), Mercier F, Manguso R, Pittet MJ
Cancer Cell – 2026 Feb 5
Hallmarks of cancer—Then and now, and beyond
Hanahan D
Cell – 2026 Jan 29
Kinetic Profiling in One-Step Digital Immunoassays Enables Multiplex Quantification across an Ultrabroad Dynamic Range.
Saateh A, Allamehnejad R, Yang W, (…), Liu YC, Tolstonog GV, Altug H
Journal of the American Chemical Society – 2026 Jan 27
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors.
Melero I, Steeghs N, Lassen U, (…), Dejardin D, Teichgräber V, Charo J
Journal for immunotherapy of cancer – 2026 Jan 16